These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 12622435)

  • 1. Five-year angiographic outcome in patients without restenosis following coronary balloon angioplasty: a comparison between non diabetic and diabetic lesions.
    Takenaka S; Nakamura N; Shiode N; Shirota K; Suyama H; Goto Y; Hirao H; Nakazawa Y; Inoue K; Nagamatsu T
    Jpn Heart J; 2003 Jan; 44(1):31-9. PubMed ID: 12622435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels.
    Van Belle E; Bauters C; Hubert E; Bodart JC; Abolmaali K; Meurice T; McFadden EP; Lablanche JM; Bertrand ME
    Circulation; 1997 Sep; 96(5):1454-60. PubMed ID: 9315531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term angiographic follow-up of coronary balloon angioplasty in patients with diabetes mellitus: a clue to the explanation of the results of the BARI study. Balloon Angioplasty Revascularization Investigation.
    Rozenman Y; Sapoznikov D; Mosseri M; Gilon D; Lotan C; Nassar H; Weiss AT; Hasin Y; Gotsman MS
    J Am Coll Cardiol; 1997 Nov; 30(6):1420-5. PubMed ID: 9362396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of angiographic restenosis after coronary intervention in patients with diabetes mellitus.
    Mazeika P; Prasad N; Bui S; Seidelin PH
    Am Heart J; 2003 Jun; 145(6):1013-21. PubMed ID: 12796757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restenosis and progression of coronary disease after balloon angioplasty in patients with diabetes mellitus.
    Rozenman Y; Sapoznikov D; Gotsman MS
    Clin Cardiol; 2000 Dec; 23(12):890-4. PubMed ID: 11129674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphologic changes during follow-up after successful percutaneous transluminal coronary balloon angioplasty: quantitative angiographic analysis in 778 lesions--further evidence for the restenosis paradox. MERCATOR Study Group (Multicenter European Research trial with Cilazapril after Angioplasty to prevent Transluminal Coronary Obstruction and Restenosis).
    Hermans WR; Foley DP; Rensing BJ; Serruys PW
    Am Heart J; 1994 Mar; 127(3):483-94. PubMed ID: 8122593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of paclitaxel drug-eluting balloon and paclitaxel-eluting stent in small coronary vessels in diabetic and nondiabetic patients - results from the BELLO (balloon elution and late loss optimization) trial.
    Giannini F; Latib A; Jabbour RJ; Costopoulos C; Chieffo A; Carlino M; Montorfano M; Menozzi A; Castriota F; Micari A; Cremonesi A; De Felice F; Marchese A; Tespili M; Presbitero P; Sgueglia GA; Buffoli F; Tamburino C; Varbella F; Colombo A
    Cardiovasc Revasc Med; 2017; 18(1):4-9. PubMed ID: 28011243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in restenosis propensity of devices for transluminal coronary intervention. A quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent implantation and excimer laser angioplasty. CARPORT, MERCATOR, MARCATOR, PARK, and BENESTENT Trial Groups.
    Foley DP; Melkert R; Umans VA; de Jaegere PP; Strikwerda S; de Feyter PJ; Serruys PW
    Eur Heart J; 1995 Oct; 16(10):1331-46. PubMed ID: 8746901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immediate and late outcome of excimer laser and balloon coronary angioplasty: a quantitative angiographic comparison based on matched lesions.
    Strikwerda S; Montauban van Swijndregt E; Foley DP; Boersma E; Umans VA; Melkert R; Serruys PW
    J Am Coll Cardiol; 1995 Oct; 26(4):939-46. PubMed ID: 7560621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Restenosis after directional coronary atherectomy and balloon angioplasty: comparative analysis based on matched lesions.
    Umans VA; Hermans W; Foley DP; Strikwerda S; van den Brand M; de Jaegere P; de Feyter PJ; Serruys PW
    J Am Coll Cardiol; 1993 May; 21(6):1382-90. PubMed ID: 8473645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term luminal renarrowing after successful elective coronary angioplasty of total occlusions. A quantitative angiographic analysis.
    Violaris AG; Melkert R; Serruys PW
    Circulation; 1995 Apr; 91(8):2140-50. PubMed ID: 7697842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergency coronary stenting for dissection during percutaneous transluminal coronary angioplasty: angiographic follow-up after stenting and after repeat angioplasty of the stented segment.
    Schömig A; Kastrati A; Dietz R; Rauch B; Neumann FJ; Katus HH; Busch U
    J Am Coll Cardiol; 1994 Apr; 23(5):1053-60. PubMed ID: 8144767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular brachytherapy using a beta emitter source in diabetic patients with in-stent restenosis: angiographic and clinical outcomes.
    Suntharalingam M; Laskey WK; Tantibhedhyangkul W; Lansky A; Teirstein P; Bass T; Silber S; Rutherford B; Wilmer C; Popma JJ; Kuntz R; Bonan R
    Int J Radiat Oncol Biol Phys; 2003 Oct; 57(2):536-42. PubMed ID: 12957267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of diabetes mellitus on long-term outcomes in the drug-eluting stent era.
    Iijima R; Ndrepepa G; Mehilli J; Markwardt C; Bruskina O; Pache J; Ibrahim M; Schömig A; Kastrati A
    Am Heart J; 2007 Oct; 154(4):688-93. PubMed ID: 17892992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Restenosis after arterial injury caused by coronary stenting in patients with diabetes mellitus.
    Carrozza JP; Kuntz RE; Fishman RF; Baim DS
    Ann Intern Med; 1993 Mar; 118(5):344-9. PubMed ID: 8430980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of restenosis and disease progression on clinical outcome after multivessel stenting in diabetic patients.
    Loutfi M; Mulvihill NT; Boccalatte M; Farah B; Fajadet J; Marco J
    Catheter Cardiovasc Interv; 2003 Apr; 58(4):451-4. PubMed ID: 12652493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short- and long-term clinical and quantitative angiographic results with the new, less shortening Wallstent for vessel reconstruction in chronic total occlusion: a quantitative angiographic study.
    Ozaki Y; Violaris AG; Hamburger J; Melkert R; Foley D; Keane D; de Feyter P; Serruys PW
    J Am Coll Cardiol; 1996 Aug; 28(2):354-60. PubMed ID: 8800109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patency of percutaneous transluminal coronary angioplasty sites at 6-month angiographic follow-up: A key determinant of survival in diabetics after coronary balloon angioplasty.
    Van Belle E; Ketelers R; Bauters C; Périé M; Abolmaali K; Richard F; Lablanche JM; McFadden EP; Bertrand ME
    Circulation; 2001 Mar; 103(9):1218-24. PubMed ID: 11238264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): immediate and long-term results.
    Rodriguez AE; Rodriguez Alemparte M; Fernandez Pereira C; Vigo CF; Sampaolesi A; Bernardi V; Marchand E; Tronge J; Palacios IF;
    Am Heart J; 2005 Jul; 150(1):188. PubMed ID: 16086559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
    Rittger H; Wöhrle J; Brachmann J; Hohenforst-Schmidt W; Schlundt C; Lonke S; von Cranach M; Markovic S; Achenbach S; Waliszewski M
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):529-534. PubMed ID: 26893095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.